Bioburden testing is a critical quality control (QC) step for contamination detection, but the traditional compendium method can fall short of today's speed and safety demands. Sample enumeration, tracking, and reporting are typically subjective, time-consuming manual processes prone to human error. In this infographic, learn how you can ease the burden of bioburden testing in pharmaceutical manufacturing and adhere to USP <1119>, USP <1119.1> and USP <61> with the Growth Direct® System.